Abstract

Alopecia areata (AA) is a hair follicle (HF) disorder, in which the immune system attacks the HF and causes reversible hair loss. Even though AA is not a life-threatening disease, an association with psychosocial diseases and a severe drop in quality of life is common (Pratt et al., 2017). There is, as yet, no approved medicine in the therapy for AA. New potent drugs, such as Jak inhibitors, show promising results but incur severe adverse effects (Wang et al., 2018). For such drugs, targeted delivery to the site of action is essential.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.